SiRNA targeting HOTAIR has been shown to suppress the progression of endometrial carcinoma in vivo, demonstrating that targeting HOTAIR can be a novel therapeutic strategy for endometrial cancer (164). This evidence concerns the gene HOTAIR and endometrial carcinoma.